BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
glucose metabolic process
,
Ischemia
,
Endothelial cell
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1-phosphatidylinositol-3-kinase regulator activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Uterus
Tongue superior part with papillae
Lung
Tonsil
Pharyngeal mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Contact dermatitis
Stachybotryotoxicosis
Muscle cachexia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CP 466722
flavopiridol
COOH-terminal signal transamidase
CGP 60474
Hydrogen
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
DDX25
NCL
PPP2R2C
TSR2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
Profile of cellular and KSHV microRNAs in KSHV infected lymphatic endothelial cells
Chemoresistant ovarian cancer miRNA expression profiles
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Apelin and APJ knockdown in pulmonary artery endothelial cells
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for 1-phosphatidylinositol-3-kinase regulator activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Replacement of Vitamin D in Patients With Active Tuberculosis
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Effect of Polyphenol-rich Dark Chocolate on Obesity
Everolimus for Children With Recurrent or Progressive Ependymoma
STAR Cape+BKM120 MBC With Brain Met
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ